Skip to main content

THE ROAD TO NASDAQ

NASDAQ CAPITAL RAISE

19%

Timeline

2023
05/27/2023

OBJECTIVE

The company aims to transition from the OTC market to Nasdaq, seizing the opportunity to expand its market presence and gain higher visibility among investors.

07/01/2023

UTILIZING A SHELL COMPANY

To expedite the process, the company plans to utilize a shell company, which is an existing publicly traded entity with no or minimal operations. By merging with this shell company, the private company can become publicly traded without going through a traditional initial public offering (IPO).

07/14/2023

FUNDRAISING

The company intends to raise up to $5 million to facilitate the transition. This capital injection will enable the company to meet the financial requirements necessary for listing on the OTC market within a timeframe of six weeks.

07/14/2023

SHARE STRUCTURE

The $5 million fundraising target will be achieved by issuing 5 million shares, priced at $1 per share. This approach allows potential investors to participate in the company’s growth while aligning the capital raise with the desired valuation

09/14/2023

OTC & NASDAQ MARKET LISTING

Upon successfully securing the $5 million in funding, the company will satisfy the financial prerequisites for listing on the OTC and Nasdaq market. This step provides an initial platform for the company’s publicly traded journey, offering improved liquidity and increased market exposure.

2024
02/21/2024

NASDAQ TRANSITION

With the initial step of achieving OTC market listing accomplished, the company can leverage its public status and growth potential to prepare for a subsequent transition to Nasdaq. This move signifies further market credibility and access to a larger investor base.